Fragment-Based Design, Synthesis, and Biological Evaluation of 1-Substituted-indole-2-carboxylic Acids as Selective Mcl-1 Inhibitors

被引:16
作者
Wang, Ziqian [1 ]
Xu, Wenjie [1 ]
Song, Ting [2 ]
Guo, Zongwei [2 ]
Liu, Lu [1 ]
Fan, Yudan [2 ]
Wang, Anhui [1 ]
Zhang, Zhichao [1 ]
机构
[1] Dalian Univ Technol, Sch Chem, State Key Lab Fine Chem, Dalian 116012, Peoples R China
[2] Dalian Univ Technol, Sch Life Sci & Technol, Dalian, Peoples R China
基金
中国国家自然科学基金;
关键词
Fragment-based drug design; Ligand efficiency; Mcl-1; inhibitor; p1; pocket; Selective; BCL-2; FAMILY; DRUG DESIGN; ABT-737; DISCOVERY; PROTEINS; POTENT; ANTAGONISTS; RESISTANCE; APOPTOSIS; BIG;
D O I
10.1002/ardp.201600251
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on a known selective Mcl-1 inhibitor, 6-chloro-3-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-1H-indole-2-carboxylic acid, we applied a fragment-based approach to obtain new molecules that extended into the p1 pocket of the BH3 groove and then exhibited binding selectivity for the Mcl-1 over the Bcl-2 protein. After we deconstructed the 1H-indole-2-carboxylic acid from the parental molecule, a benzenesulfonyl was substituted at the 1-position to adopt a geometry preferred for accessing the p1 pocket according to the binding mode of the parental molecule identified by X-ray crystallography. A linear relationship between the free energy of ligand binding (Delta G) and the count of non-hydrogen heavy atoms (HAC) was maintained during the molecular growing to occupy the p1 pocket. Finally, we not only obtained compound 12 with a 7.5-fold selectivity to Mcl-1 (K-i = 0.48 mu M by fluorescence polarization) over Bcl-2 (K-i = 3.6 mu M), but also provided evidence that additional occupation of the p1 pocket is more favorable for Mcl-1 than for Bcl-2 binding, and contributes more to Mcl-1 inhibition than occupation of the p2 pocket. Compound 12 exhibited a selective killing ability on Mcl-1-dependent cancer cells.
引用
收藏
页数:12
相关论文
共 50 条
[31]   Rational Design of Proteolytically Stable, Cell-Permeable Peptide-Based Selective Mcl-1 Inhibitors [J].
Muppidi, Avinash ;
Doi, Kenichiro ;
Edwardraja, Selvakumar ;
Drake, Eric J. ;
Gulick, Andrew M. ;
Wang, Hong-Gang ;
Lin, Qing .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2012, 134 (36) :14734-14737
[32]   Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Thiazolidine-2,4-dione Derivatives as Mcl-1 Inhibitors [J].
Deng, Xu ;
Long, Jiabing ;
Wang, Wenyan ;
Xia, Shen ;
Wan, Yichao .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (03) :464-469
[33]   Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of Indazole Derivatives as Bcl-2/Mcl-1 Dual Inhibitors [J].
Luo, Xi ;
Deng, Xu ;
Ruan, Jingyi ;
Wang, Wenyan ;
Wan, Yichao .
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (06) :1109-1114
[34]   In silico design of potential Mcl-1 peptide-based inhibitors [J].
Naser Faraji ;
Norelle L. Daly ;
Seyed Shahriar Arab ;
Ahmad Yari Khosroushahi .
Journal of Molecular Modeling, 2024, 30
[35]   Novel soluble myeloid cell leukemia sequence 1 (Mcl-1) inhibitor (E,E)-2-(benzylaminocarbonyl)-3-styrylacrylonitrile (4g) developed using a fragment-based approach [J].
Zhang, Zhichao ;
Song, Ting ;
Li, Xiangqian ;
Wu, Zhiyong ;
Feng, Yingang ;
Xie, Feibo ;
Liu, Chengwu ;
Qin, Jianquan ;
Chen, Hongbo .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 59 :141-149
[36]   Indole-3-Carbonitriles as DYRK1A Inhibitors by Fragment-Based Drug Design [J].
Meine, Rosanna ;
Becker, Walter ;
Falke, Hannes ;
Preu, Lutz ;
Loaec, Nadege ;
Meijer, Laurent ;
Kunick, Conrad .
MOLECULES, 2018, 23 (02)
[37]   Scaffold hopping from indoles to indazoles yields dual MCL-1/BCL-2 inhibitors from MCL-1 selective leads [J].
Drennen, Brandon ;
Goodis, Christopher C. ;
Bowen, Nathan ;
Yu, Wenbo ;
Vickers, Gregory ;
Wilder, Paul T. ;
MacKerell, Alexander D., Jr. ;
Fletcher, Steven .
RSC MEDICINAL CHEMISTRY, 2022, 13 (08) :963-969
[38]   Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors [J].
Cui, Guonan ;
Lai, Fangfang ;
Wang, Xiaoyu ;
Chen, Xiaoguang ;
Xu, Bailing .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 188
[39]   Probing the difference between BH3 groove of Mcl-1 and Bcl-2 protein: Implications for dual inhibitors design [J].
Zhang, Zhichao ;
Yang, Hongna ;
Wu, Guiye ;
Li, Zhiqiang ;
Song, Ting ;
Li, Xiang Qian .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) :3909-3916
[40]   Discovery and development of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as Bcl-2/Mcl-1 inhibitors [J].
Liu, Renshuai ;
Liu, Lulu ;
Yang, Xinying ;
Fang, Hao .
BIOORGANIC CHEMISTRY, 2019, 88